Clinical Trial Update: National Network for the Study of Predictors and Prevention of Sudden Unexpected Death in Drug-resistant Partial Epilepsies

View source ↗

Summary

Clinical trial conducted by Hospices Civils de Lyon on predictors and prevention of sudden unexpected death in drug-resistant partial epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Epilepsy

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Drug-resistant Partial Epilepsy | Status: COMPLETED